Constitutive Expression of MHC Class II Genes in Melanoma Cell Lines Results from the Transcription of Class II Transactivator Abnormally Initiated from Its B Cell-Specific Promoter1

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of Immunology

• Publication date

  2001-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.167.1.98PMID 11418637
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The RAG cell line defines a new complementation group of MHC class II deficiency

  2005cited by this paper
• Cutting Edge: The Class II Transactivator Prevents Activation-Induced Cell Death by Inhibiting Fas Ligand Gene Expression1

  2001cited by this paper
• Transcriptional Scaffold: CIITA Interacts with NF-Y, RFX, and CREB To Cause Stereospecific Regulation of the Class II Major Histocompatibility Complex Promoter

  2000cited by this paper
• Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene

  2000cited by this paper
• Identification of CD4+ T Cell Epitopes from NY-ESO-1 Presented by HLA-DR Molecules

  2000cited by this paper
• Melanoma Cells Present a MAGE-3 Epitope to CD4+ Cytotoxic T Cells in Association with Histocompatibility Leukocyte Antigen DR11

  1999cited by this paper
• Class II MHC genes: a model gene regulatory system with great biologic consequences.

  1999cited by this paper
• Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV Melanoma

  1999cited by this paper
• Differential expression of MHC class II isotype chains.

  1999cited by this paper
• CD4 T Cells and Their Role in Antitumor Immune Responses

  1999cited by this paper
• IL-1β Inhibits IFN-γ-Induced Class II MHC Expression by Suppressing Transcription of the Class II Transactivator Gene

  1999cited by this paper
• Two Distinct Gamma Interferon-Inducible Promoters of the Major Histocompatibility Complex Class II Transactivator Gene Are Differentially Regulated by STAT1, Interferon Regulatory Factor 1, and Transforming Growth Factor β

  1999cited by this paper
• IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.

  1999cited by this paper
• Can immunohistochemical markers and mitotic rate improve prognostic precision in patients with primary melanoma?

  1999cited by this paper
• CREB regulates MHC class II expression in a CIITA-dependent manner.

  1999cited by this paper
• Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1.

  1998cited by this paper
• Quantitative control of MHC class II expression by the transactivator CIITA

  1998cited by this paper
• Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

  1998cited by this paper
• Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.

  1998cited by this paper
• A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients

  1998cited by this paper
• CIITA B-cell-specific promoter suppression in MHC class II-silenced cell hybrids

  1998cited by this paper
• Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.

  1998cited by this paper
• Induction of antigen-specific T cell anergy: An early event in the course of tumor progression.

  1998cited by this paper
• Identification of Distinct Regions of 5′ Flanking DNA That Mediate Constitutive, IFN-γ, STAT1, and TGF-β-Regulated Expression of the Class II Transactivator Gene

  1998cited by this paper
• RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency

  1997cited by this paper
• Isolation of a B-cell-specific promoter for the human class II transactivator

  1997cited by this paper
• Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA

  1997influential reference
• Cancer Tumor antigens.

  1997cited by this paper
• The control of gene expression in melanocytes and melanomas.

  1996cited by this paper
• Melanoma-specific CD4+ T cells recognize nonmutated HLA-DR-restricted tyrosinase epitopes

  1996cited by this paper
• The control of gene expression in melanocytes and melanomas.

  1996cited by this paper
• A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).

  1995cited by this paper
• Transcriptional responses to polypeptide ligands: the JAK-STAT pathway.

  1995cited by this paper
• Organ-specific autoimmunity.

  1995cited by this paper
• The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells.

  1995cited by this paper
• The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.

  1995cited by this paper
• Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA.

  1994cited by this paper
• Evidence for retinoblastoma protein (RB) dependent and independent IFN-gamma responses: RB coordinately rescues IFN-gamma induction of MHC class II gene transcription in noninducible breast carcinoma cells.

  1994cited by this paper
• Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA

  1994cited by this paper
• Multiple sub‐sets of Cd4+ and Cd8+ cytotoxic T‐cell clones directed to autologous human melanoma identified by cytokine profiles

  1994cited by this paper
• Pathology and prognostic factors

  1993cited by this paper
• Tumor escape mechanisms from immunosurveillance: induction of unresponsiveness in a specific MHC-restricted CD4+ human T cell clone by the autologous MHC class II+ melanoma.

  1993cited by this paper
• Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).

  1993influential reference
• Spacing and orientation of bipartite DNA-binding motifs as potential functional determinants for POU domain factors.

  1993cited by this paper
• Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome.

  1993cited by this paper
• Monoclonal antibodies to NF‐Y define its function in MHC class II and albumin gene transcription.

  1992cited by this paper
• Sequences and factors: a guide to MHC class-II transcription.

  1992influential reference
• Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.

  1987cited by this paper
• Organ‐Specific Autoimmunity: A 1986 Overview

  1986cited by this paper
• Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts

  1985cited by this paper
• Distribution of class IIDQ antigens on normal and leukemic lymphoid cells

  1985cited by this paper
• Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.

  1984cited by this paper
• HLA-DR antigen expression in primary melanomas of the skin.

  1984cited by this paper
• Detection of a novel human class II HLA antigen

  1983cited by this paper
• Expression of Ia-like antigens on cultured human malignant melanoma cell lines.

  1978cited by this paper
• Regulation of Cytomegalovirus Gene Expression : a and Promoters Are trans Activated by Viral Functions in Permissive Human Fibroblasts

  year unknowncited by this paper

• The aryl hydrocarbon receptor (AHR) drives human leukocyte antigen (HLA)-II expression in human melanoma.

  2026cites this paper
• Extracellular vesicles released from melanoma cells constitutively expressing MHC class II promote immune evasion and cancer progression.

  2026cites this paper
• MHC class II: a predictor of outcome in melanoma treated with immune checkpoint inhibitors

  2025cites this paper
• Immune-mediated Engagement of T Regulatory Cells with Tumor Cells Results in Trogocytosis and Tumor Cell Killing

  2025cites this paper
• Uncoupling CD4+ TIL-mediated tumor killing from JAK-signaling in melanoma.

  2023cites this paper
• Major histocompatibility complex class II in the tumor microenvironment: functions of nonprofessional antigen-presenting cells.

  2023cites this paper
• Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance

  2023cites this paper
• Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities

  2023cites this paper
• The HLA-II immunopeptidome of SARS-CoV-2

  2023cites this paper
• High GILT Expression Is Associated with Improved Survival in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition

  2022cites this paper
• Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling

  2022cites this paper
• Identification of bacteria-derived HLA-bound peptides in melanoma

  2021cites this paper
• Global and context-specific transcriptional consequences of oncogenic Fbw7 mutations

  2021cites this paper
• A Multi-Omics Analysis of Metastatic Melanoma Identifies a Germinal Center-Like Tumor Microenvironment in HLA-DR-Positive Tumor Areas

  2021cites this paper
• Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD)

  2020cites this paper
• Helicobacter pylori Dampens HLA-II Expression on Macrophages via the Up-Regulation of miRNAs Targeting CIITA

  2020cites this paper
• Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy

  2020cites this paper
• Overcoming Cancer Tolerance with Immune Checkpoint Blockade

  2020cites this paper
• Therapeutic applications of the selective high affinity ligand drug SH7139 extend beyond non-Hodgkin’s lymphoma to many other types of solid cancers

  2020cites this paper
• Expressions of HLA Class II Genes in Cutaneous Melanoma Were Associated with Clinical Outcome: Bioinformatics Approaches and Systematic Analysis of Public Microarray and RNA-Seq Datasets

  2019cites this paper
• The local immune response in melanoma. In situ analysis of the micro-environmental immune-signature of primary melanoma.

  2018cites this paper
• Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion

  2018cites this paper
• Biological Consequences of MHC-II Expression by Tumor Cells in Cancer

  2018cites this paper
• Xue, Wei and Metheringham, Rachael L. and Brentville, Victoria A. and Gunn, Barbara and Symonds, Peter and Yagita, Hideo and Ramage, Judith M. and Durrant, Lindy (2016) SCIB2, an antibody DNA vaccine encoding NY- ESO-1 epitopes, induces potent antitumor immunity

  2018cites this paper
• Immune and molecular correlates in melanoma treated with immune checkpoint blockade

  2017cites this paper
• The HLA-DR mediated signalling increases the migration and invasion of melanoma cells, the expression and lipid raft recruitment of adhesion receptors, PD-L1 and signal transduction proteins.

  2017cites this paper
• The HLA DPB1*02:01:02 and DQB1*05:02:01 alleles as possible risk factors for colorectal carcinoma in the Malaysian population

  2016cites this paper
• SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade

  2016cites this paper
• Conservation of immune gene signatures in solid tumors and prognostic implications

  2016cites this paper
• T Cells Derived From Human Melanoma Draining Lymph Nodes Mediate Melanoma-specific Antitumor Responses In Vitro and In Vivo in Human Melanoma Xenograft Model

  2015cites this paper
• Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity.

  2015cites this paper
• Gamma-interferon-inducible lysosomal thiol reductase is upregulated in human melanoma

  2015cites this paper
• High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma

  2014cites this paper
• Direct recognition of tumors by regulatory T-cells with suppression of immune rejection.

  2014influential citation
• GILT: Shaping the MHC Class II-Restricted Peptidome and CD4+ T Cell-Mediated Immunity

  2013cites this paper
• Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001

  2012cites this paper
• Contrasting effects of IFNα on MHC class II expression in professional vs. nonprofessional APCs: Role of CIITA type IV promoter.

  2012cites this paper
• Effects of human leukocyte antigen (HLA)-DR engagement on melanoma cells.

  2011cites this paper
• MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis

  2011cites this paper
• Resistance to Apoptosis LAG-3 (CD223) Contributes to Melanoma MHC Class II Engagement by Its Ligand

  2011cites this paper
• OPINION: Immunologic Abnormality of Intrahepatic Cholestasis of Pregnancy

  2010cites this paper
• Distinct MHC gene expression patterns during progression of melanoma

  2009cites this paper
• Linkage of a tumor immune function and cell cycle de-regulation via a gene regulatory network subcircuit.

  2009cites this paper
• Coexpression of major histocompatibility complex class II with chemokines and nuclear NFκB p50 in melanoma: a rational for their association with poor prognosis

  2009cites this paper
• Epithelial Human Leukocyte Antigen-DR Expression Predicts Reduced Recurrence Rates and Prolonged Survival in Rectal Cancer Patients

  2008cites this paper
• Epithelial Human LeukocyteAntigen-DRExpression Predicts Reduced Recurrence Rates and Prolonged Survival in Rectal Cancer Patients

  2008cites this paper
• Pathologic expression of MHC class II is driven by mitogen‐activated protein kinases

  2007cites this paper
• Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.

  2007cites this paper
• A fresh look at an old story: revisiting HLA class II antigen expression by melanoma cells

  2006cites this paper
• Effect of interferon alpha on MHC class II gene expression in ex vivo human islet tissue.

  2006cites this paper
• Hexim1 sequesters positive transcription elongation factor b from the class II transactivator on MHC class II promoters

  2006cites this paper
• CTL-Tumor Cell Interaction: The Generation of Molecular Probes of Monitoring the HLA-A*0201-HER-2/neu Peptide Complex

  2005cites this paper
• CIITA transformation rescues the apoptotic function of MHC class II in melanoma cells.

  2005cites this paper
• Compartmentalization of class II antigen presentation: contribution of cytoplasmic and endosomal processing

  2005cites this paper
• Regulation of MHC class II gene expression by the class II transactivator

  2005cites this paper
• HLA Antigen Changes in Malignant Tumors of Mammary Epithelial Origin: Molecular Mechanisms and Clinical Implications

  2004cites this paper
• Reply: CIITA methylation and decreased levels of HLA-DR in tumour progression

  2004cites this paper
• Cutting Edge: Induction of the Antigen-Processing Enzyme IFN-γ-Inducible Lysosomal Thiol Reductase in Melanoma Cells Is STAT1-Dependent but CIITA-Independent1

  2004cites this paper
• HLA-DR signaling inhibits Fas-mediated apoptosis in A375 melanoma cells.

  2004cites this paper
• Class II transactivator (CIITA) isoform expression and activity in melanoma

  2004cites this paper
• Mini‐review: Specificity and expression of CIITA, the master regulator of MHC class II genes

  2004cites this paper
• Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA)

  2004cites this paper
• Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-γ in haematopoietic tumour cells

  2004cites this paper
• CIITA-Independent Cells Is STAT 1-Dependent but Lysosomal Thiol Reductase in Melanoma-Inducible γ Antigen-Processing Enzyme IFN-Cutting Edge : Induction of the

  2004cites this paper
• Components of the IFN-γ Signaling Pathway in Tumorigenesis

  2003cites this paper
• Splicing defect in RFXANK results in a moderate combined immunodeficiency and long-duration clinical course

  2003cites this paper
• Toxoplasma gondii inhibits MHC class II expression in neural antigen-presenting cells by down-regulating the class II transactivator CIITA.

  2003cites this paper
• On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases

  2003cites this paper
• Mutations and regulatory anomalies effecting tumor cell immune functions

  2003cites this paper
• Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression.

  2003cites this paper
• Genetic control of MHC class II expression.

  2002cites this paper
• Regulation of Class II MHC Expression in APCs: Roles of Types I, III, and IV Class II Transactivator1

  2002cites this paper
• MHC class II-deficient tumor cell lines with a defective expression of the class II transactivator.

  2002cites this paper
• Isoforms of the class II transactivator protein.

  2002cites this paper
• The PanAmerican Society for Pigment Cell Ressarch

  2002cites this paper
• Components of the IFN-gamma signaling pathway in tumorigenesis.

  2002cites this paper
• Expression and Characterization of the MHC Class II Transactivator in K-562 Cells

  2001cites this paper
• Malignant glioma cells use MHC class II transactivator (CIITA) promoters III and IV to direct IFN‐γ‐inducible CIITA expression and can function as nonprofessional antigen presenting cells in endocytic processing and CD4+ T‐cell activation

  2001cites this paper